A multicenter retrospective observational study to determine safety and toxicity in patients with metastatic colorectal cancer receiving TAS-102 in Spanish hospitals
Latest Information Update: 16 Nov 2021
At a glance
- Drugs Tipiracil/trifluridine (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 21 Sep 2021 Results assessing efficacy and safety of TAS-102 in patients with refractory metastatic colorectal cancer, presented at the 46th European Society for Medical Oncology Congress.
- 20 Aug 2021 New trial record
- 03 Jul 2021 Results presented at the 23rd World Congress on Gastrointestinal Cancer